imipramine has been researched along with Deafness in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Deafness: A general term for the complete loss of the ability to hear from both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roy, JY | 1 |
| Colard, R | 1 |
| Tétreault, L | 1 |
1 trial available for imipramine and Deafness
| Article | Year |
|---|---|
[Psychopharmacological aspects of the use of imipramine in enuresis in 26 deaf-mutes].
Topics: Adolescent; Child; Clinical Trials as Topic; Deafness; Enuresis; Humans; Imipramine; Male; Placebos | 1970 |